Failure to reduce benzodiazepine prescriptions through the implementation of a psychological intervention for insomnia in an Italian mental health service
- PMID: 38536419
- DOI: 10.1007/s00228-024-03677-7
Failure to reduce benzodiazepine prescriptions through the implementation of a psychological intervention for insomnia in an Italian mental health service
Abstract
Purpose: Despite the evidence of higher effectiveness of psychological interventions for insomnia compared to pharmacological ones, drug prescriptions for insomnia remain frequent. This study has assessed patterns of prescriptions of BZDs for insomnia before and after the delivery of a training in psychological interventions to professionals working in the services of a Department of Mental Health in northern Italy.
Methods: The intervention consisted in two training sessions about psychological interventions for insomnia delivered to professionals of the participating services. The prevalence of users with a prescription of BZDs for insomnia in an index period after the delivery of the training was compared to the prevalence in an index period before the training.
Results: Among 727 people assessed for BZDs prescription at pre-intervention, 306 (42.1%, 95% CI 0.39-0.46) had a prescription, and 344 (49.2%, 95% CI 0.45-0.53) had a prescription among 699 people assessed at post-intervention, corresponding to a significant odds ratio of 1.33 to be prescribed with BZDs in the second index period compared to the first one. Psychological interventions were offered to a small group of patients.
Conclusion: Prescribing attitudes of BZDs for insomnia were not modified after the training and delivery of a psychological intervention in a mental healthcare outpatient setting. Prescribing habits should be addressed more directly in training, and professionals should be more aware of risks of BZDs assumption. The failure in changing drug prescriptions in this study should prompt more real-world studies of the application of evidence-based strategies, particularly in outpatient mental health settings.
Keywords: Benzodiazepine; CBT; Deprescribing; Education; Insomnia; Sleep hygiene.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Trends in anti-insomnia medication utilization among pediatric patients in nine cities in China: A real-world study (2016-2023).Sleep Med. 2025 Mar;127:28-35. doi: 10.1016/j.sleep.2025.01.004. Epub 2025 Jan 4. Sleep Med. 2025. PMID: 39787818
-
Barriers to nonpharmacologic treatments for stress, anxiety, and insomnia: family physicians' attitudes toward benzodiazepine prescribing.Can Fam Physician. 2010 Nov;56(11):e398-406. Can Fam Physician. 2010. PMID: 21075981 Free PMC article.
-
Patient Characteristics and Practice Variation Associated With New Community Prescription of Benzodiazepine and z-Drug Hypnotics After Critical Illness: A Retrospective Cohort Study Using the UK Clinical Practice Research Datalink.Pharmacoepidemiol Drug Saf. 2024 Dec;33(12):e70056. doi: 10.1002/pds.70056. Pharmacoepidemiol Drug Saf. 2024. PMID: 39603606 Free PMC article.
-
Psychological treatment for insomnia in the regulation of long-term hypnotic drug use.Health Technol Assess. 2004 Feb;8(8):iii-iv, 1-68. doi: 10.3310/hta8080. Health Technol Assess. 2004. PMID: 14960254 Review.
-
Prescription Benzodiazepine Use Among Older Adults: A Critical Review.Harv Rev Psychiatry. 2018 Sep/Oct;26(5):264-273. doi: 10.1097/HRP.0000000000000190. Harv Rev Psychiatry. 2018. PMID: 30188338 Free PMC article. Review.
References
-
- Riemann D, Espie CA, Altena E et al (2023) The European Insomnia Guideline: an update on the diagnosis and treatment of insomnia 2023. J Sleep Res 32:e14035. https://doi.org/10.1111/jsr.14035 - DOI - PubMed
-
- Palagini L, Manni R, Aguglia E et al (2020) Expert opinions and consensus recommendations for the evaluation and management of insomnia in clinical practice: joint statements of five Italian scientific societies. Front Psychiatry. https://doi.org/10.3389/fpsyt.2020.00558 - DOI - PubMed - PMC
-
- OSMED (2023) Osservatorio Nazionale sull’impiego dei Medicinali. L’uso dei Farmaci in Italia. Rapporto Nazionale Anno 2022. Roma: Agenzia Italiana del Farmaco
-
- OSMED (2022) Osservatorio Nazionale sull’impiego dei Medicinali. L’uso dei Farmaci in Italia. Rapporto Nazionale Anno 2021. Roma: Agenzia Italiana del Farmaco
-
- Veronese A, Garatti M, Cipriani A, Barbui C (2007) Benzodiazepine use in the real world of psychiatric practice: low-dose, long-term drug taking and low rates of treatment discontinuation. Eur J Clin Pharmacol 63:867–873. https://doi-org.mu.idm.oclc.org/ https://doi.org/10.1007/s00228-007-0341-1
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical